| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2172* | 2021 |
| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 1057 | 2021 |
| The promise and peril of chemical probes CH Arrowsmith, JE Audia, C Austin, J Baell, J Bennett, J Blagg, C Bountra, ... Nature chemical biology 11 (8), 536-541, 2015 | 863 | 2015 |
| Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination M Vedadi, FH Niesen, A Allali-Hassani, OY Fedorov, PJ Finerty Jr, ... Proceedings of the National Academy of Sciences 103 (43), 15835-15840, 2006 | 743 | 2006 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 465* | 2021 |
| A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases O Fedorov, B Marsden, V Pogacic, P Rellos, S Müller, AN Bullock, ... Proceedings of the National Academy of Sciences 104 (51), 20523-20528, 2007 | 420 | 2007 |
| High-throughput production of human proteins for crystallization: the SGC experience P Savitsky, J Bray, CDO Cooper, BD Marsden, P Mahajan, ... Journal of structural biology 172 (1), 3-13, 2010 | 358 | 2010 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 321 | 2020 |
| Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom J Wei, N Stoesser, PC Matthews, D Ayoubkhani, R Studley, I Bell, JI Bell, ... Nature microbiology 6 (9), 1140-1149, 2021 | 309 | 2021 |
| Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases P Canning, CDO Cooper, T Krojer, JW Murray, ACW Pike, A Chaikuad, ... Journal of Biological Chemistry 288 (11), 7803-7814, 2013 | 309 | 2013 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 285 | 2020 |
| Structures of ABCB10, a human ATP-binding cassette transporter in apo-and nucleotide-bound states CA Shintre, ACW Pike, Q Li, JI Kim, AJ Barr, S Goubin, L Shrestha, J Yang, ... Proceedings of the National Academy of Sciences 110 (24), 9710-9715, 2013 | 281 | 2013 |
| A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density NM Pearce, T Krojer, AR Bradley, P Collins, RP Nowak, R Talon, ... Nature communications 8 (1), 15123, 2017 | 260 | 2017 |
| 3, 5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands DS Hewings, M Wang, M Philpott, O Fedorov, S Uttarkar, ... Journal of medicinal chemistry 54 (19), 6761-6770, 2011 | 259 | 2011 |
| Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit PV Fish, P Filippakopoulos, G Bish, PE Brennan, ME Bunnage, AS Cook, ... Journal of medicinal chemistry 55 (22), 9831-9837, 2012 | 258 | 2012 |
| Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines J Wei, KB Pouwels, N Stoesser, PC Matthews, I Diamond, R Studley, ... Nature Medicine 28 (5), 1072-1082, 2022 | 216 | 2022 |
| Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase AN Bullock, JÉ Debreczeni, OY Fedorov, A Nelson, BD Marsden, S Knapp Journal of medicinal chemistry 48 (24), 7604-7614, 2005 | 205 | 2005 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 201 | 2021 |
| Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey KB Pouwels, T House, E Pritchard, JV Robotham, PJ Birrell, A Gelman, ... The Lancet Public Health 6 (1), e30-e38, 2021 | 199 | 2021 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ... Cell 185 (5), 916-938. e58, 2022 | 197 | 2022 |
Frank von DelftPrincipal Investigator: Protein Crystallography, SGC, Oxford UniversityVerified email at sgc.ox.ac.uk
